News

Discover how Noah Medical showcases the diagnostic confidence of its Galaxy System at AABIP 2024 with interactive simulations and field results. Join the innovative medical robotics company at the ...

Discover how Noah Medical's Galaxy System™ utilizes TiLT+ Technology to achieve 100% tool-in-lesion confirmation and up to 94.7% diagnostic yield in navigating peripheral pulmonary nodules. Explore ...

Discover how the Galaxy System by Noah Medical is revolutionizing lung biopsy diagnosis with high diagnostic yield and integrated imaging technology. Explore the latest field data from leading ...

Noah Medical is recognized as a top medical technology company for its innovative approach to early lung cancer diagnosis and treatment with the Galaxy System. Learn more about their groundbreaking ...

Noah Medical today announced that the 500th use of its Galaxy System in the United States was conducted at CHI Memorial in Chattanooga by Dr. Krish Bhadra.

Advanced, integrated solution for navigated bronchoscopy expands, trial now underway in Asia

Fierce recognized next generation bronchoscopy robot for its advances in minimally invasive peripheral lung navigation

New data demonstrating the navigational success and safety of its Galaxy System from the platform’s first in-human trial presented at AABIP 2023.

Medical robotics innovator Noah Medical today announced that the first use of its Galaxy System in the United States was conducted at the University of Chicago Medicine by Dr. Kyle Hogarth.

Medical Robotics Innovator Wins Honors from MedTech Breakthrough and Bay Area Business Journals on Heels of $150 Million Series B Announcement and Recent FDA Clearance